Weekly shot tested for rare lung disease
NCT ID NCT04722887
Summary
This study tested the safety of two different doses of a weekly injection for people with Alpha-1 Antitrypsin Deficiency, a genetic condition that can cause lung disease. Seventeen adults with moderate lung impairment received the injections under the skin for eight weeks. The main goal was to see how well people tolerated the treatment and to check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPHA1-ANTITRYPSIN DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Medical University of South Carolina - Children's Hospital
Charleston, South Carolina, 29425, United States
-
UCLA Medical Center
Los Angeles, California, 90025, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.